AIFF

Firefly Neuroscience, Inc. (NASDAQ:AIFF) is a Canadian medical technology and artificial intelligence company founded in 2002 and based in Toronto. The company develops neuroscientific solutions designed to improve diagnostic and treatment outcomes for patients suffering from mental illnesses and neurological disorders. Despite being publicly traded since 2002, Firefly remains in the early commercialization stage of its primary product offering, with minimal revenue generation and significant ongoing losses as it works to establish market presence in the specialized field of brain network analytics.